Furthermore, IGF2BP1 promotes serum response factor-dependent transcription in cancer in an m6A-dependent manner28, whereas IGF2BP2 targets m6A-containing differentiation-antagonizing non-protein-coding RNA (DANCR) to enhance its translation, with IGF2BP2 and DANCR jointly promoting the occurrence of pancreatic cancer29. Here, IGF2BP2 is linked to cancer.